對於患有呼吸器依賴性脊髓損傷和中樞性低通氣症候群的患者，橫膈膜起搏（DP）是一種有用且經濟有效的機械通氣替代方法。應仔細篩檢脊髓損傷患者，以評估其膈神經的完整性。對於符合條件的患者，膈肌起搏可改善其活動能力、言語能力、嗅覺能力和生活品質。膈肌起搏的另一種應用（儘管並不常見）是治療頑固性呃逆患者。
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (External Diaphragm Pacemaker and Internal Diaphragm Pacemaker), Application (Spinal Cord Injuries (SCI)), (Amyotrophic Lateral Sclerosis (ALS)), Chronic Pain, Parkinson’s Disease, Urine Incontinence, Epilepsy) – Industry Trends and Forecast to 2032
.
The Global Diaphragm Pacing Device Market size was valued at USD 4.68 USD Million in 2024.
The Global Diaphragm Pacing Device Market is projected to grow at a CAGR of 5.4% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
